These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients. Propping P; Friedl W Psychopharmacology (Berl); 1979 Nov; 65(3):265-72. PubMed ID: 117498 [TBL] [Abstract][Full Text] [Related]
33. Platelet monoamine oxidase activity in patients with chronic schizophrenic illnesses untreated by neuroleptic drugs [proceedings]. Bailey AR; Crow TJ; Johnstone EC; Owen F Br J Clin Pharmacol; 1975 Aug; 2(4):380P. PubMed ID: 1234010 [No Abstract] [Full Text] [Related]
34. Platelet monoamine oxidase as a function of nongenetic factors. Friedhoff AJ; Miller JC Schizophr Bull; 1980; 6(2):314-9. PubMed ID: 6103576 [TBL] [Abstract][Full Text] [Related]
35. Antipsychotic and MAO activities. Becker RE Am J Psychiatry; 1983 Jul; 140(7):955-7. PubMed ID: 6134476 [No Abstract] [Full Text] [Related]
36. Monoamine oxidase in schizophrenia: an overview. Wyatt RJ; Potkin SG; Bridge TP; Phelps BH; Wise CD Schizophr Bull; 1980; 6(2):199-207. PubMed ID: 7375851 [TBL] [Abstract][Full Text] [Related]
37. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups. Wise CD; Bridge TP; Potkin SG; Wyatt RJ Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348 [TBL] [Abstract][Full Text] [Related]
38. Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients. Meltzer HY; Stahl SM Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):419-31. PubMed ID: 4594367 [No Abstract] [Full Text] [Related]